Email Us
Cryoablation For Pancreatic Cancer

Cryoablation For Pancreatic Cancer

Key Advantages of Cryoablation in Pancreatic Cancer Treatment(1-5)


  • Precise and Safe Tumor Ablation

Guided by ultrasound and CT, cryoablation enables real-time monitoring of ice ball formation for precise tumor targeting, safeguarding vital vessels and tissues, and greatly reducing puncture-related complications like pancreatic fistula and bleeding


  • Minimally Invasive, Short Procedure Time, and Fast Recovery

Minimally invasive with shorter procedure time, cryoablation causes less trauma and enables faster recovery and reduced hospital stay, making it ideal for advanced patients unsuitable for major surgery


  • Stimulates Antitumor Immune Response and Promotes Combination Therapy

Cryoablation-induced tumor destruction releases abundant antigens that activate the immune system, supporting tumor control. Combined with radiotherapy, chemotherapy, or immunotherapy, it enhances treatment efficacy and improves survival.


References

  1. Qian, Z., et al. (2022). The clinical and experimental study of ablation therapy combined with chemotherapy or chemotherapy alone in the treatment of stage IV pancreatic cancer. Journal of Nanjing Medical University (Natural Sciences), 42(6), 849–853. 

  2. Qian, Z. et al. (2021). The clinical study of intraoperative cryoablation therapy and intraoperative combined cryoablation and hyperthermia in the treatment of unresectable pancreatic cancer. Journal of Nanjing Medical University (Natural Sciences), 41(8), 1203–1207. 

  3. Luo, X.M. et al. (2016). Advances in cryoablation for pancreatic cancer. PMC, PMC4716077.

  4. He, L. et al. (2017). Clinical Practice Guidelines for Cryosurgery of Pancreatic Cancer. PMC, PMC5555970.

  5. Zhang, C. et al. (2024). Perioperative outcomes and long-term survival of cryosurgery on unresectable pancreatic cancer: a meta-analysis. PMC, PMC11254304.


Pancreas Cancer Case Sharing
Case 1
Cryoablation for pancreatic cancer survival
cryoablation surgery for pancreas
Case 2
Puncture through left lobe of liver
cryoablation treatment for pancreas
Case 3
Puncture through dorsal approach
cryoablation therapy for pancreas
Other Cryoablation Cancer Treatment
Contact Us
Contact Us
Hygea Medical Latest News
Hygea Co-Ablation System for Lung Tumors: Clinical Evidence from a Large Retrospective Study
Hygea Co-Ablation System for Lung Tumors: Clinical Evidence from a Large Retrospective Study
New clinical data published in European Journal of Radiology demonstrate that the Hygea Co-Ablation System is a safe and feasible option for the treatment of malignant lung tumors. In more than 200 tr...
READ MORE
Ablation Plus Continuous Anti–PD-1/PD-L1 Therapy in Advanced NSCLC With Oligo-Residual Disease: The BOOSTER Randomized Phase II Trial
Ablation Plus Continuous Anti–PD-1/PD-L1 Therapy in Advanced NSCLC With Oligo-Residual Disease: The BOOSTER Randomized Phase II Trial
Shuo Yang, et al[Abstract]Treatment strategies for advanced non–small cell lung cancer (NSCLC) patients who develop oligo-residual disease (ORD) after responding to immunotherapy remain undefined. Th...
READ MORE
The first randomized phase II trial evaluating ablation plus immunotherapy in advanced NSCLC with oligo-residual disease
The first randomized phase II trial evaluating ablation plus immunotherapy in advanced NSCLC with oligo-residual disease
The BOOSTER study offers the first prospective evidence that adding local ablation to ongoing anti–PD-1/L1 therapy can improve disease control in advanced NSCLC patients with oligo-residual disease. ...
READ MORE